Collate

AI platform that creates and streamlines regulatory documentation across diagnostic, medical-device, and drug development.

Collate, founded in 2024 and headquartered in San Francisco, California, builds an AI platform that creates and streamlines regulatory and technical documentation for diagnostic, medical-device, and drug-development companies across the product lifecycle. The company reports roughly $125M raised, including a 2026 Series A led by Redpoint Ventures. Atlas found no vendor-held security certifications documented on its public site; generated documents are AI drafts requiring expert review before submission.

Headquarters
San Francisco, United States
Founded
2024
Deployment options
cloud
Website
https://collate.com

Categories

AI Use Cases

  • Regulatory Submission Authoring

Vendor Scorecard

57% — Partial coverage. Coverage score — how completely Atlas documents Collate across 7 buyer-evaluation areas. Reflects available Atlas data, not solution quality.

Compliance & Validation — Not documented by Atlas

Ask the vendor: Which compliance certifications (HIPAA, 21 CFR Part 11, SOC 2, GxP) do you hold?

Deployment & Hosting — Documented

cloud

Pricing Transparency — Not documented by Atlas

Ask the vendor: What is your pricing model, and what drives total cost of ownership?

Implementation & Onboarding — Not documented by Atlas

Ask the vendor: What is a realistic implementation timeline, and what onboarding support is included?

Organization & Role Fit — Documented

Biotech Startup, Mid-Size Biotech, Large Pharma, Top 20 Pharma, Regulatory Affairs, R&D Leadership

Solution Scope — Documented

Natural Language Processing, Regulatory Submission Authoring

Company Viability — Documented

Series A, $125M raised, Founded 2024

Always ask the vendor

Not captured in Atlas data — confirm directly. Excluded from the score above.

Data Rights & IP

Who owns model outputs? Is our proprietary data used to train models others can access, and where does our data reside?

Model Credibility & Explainability

Can you share validation studies or benchmarks, explain how the model reaches its conclusions, and describe how bias and drift are monitored?

Questions to Ask This Vendor

  • Which document types and regulatory pathways are supported in production today?
  • How does the review workflow document human sign-off on generated content?
  • How is our proprietary product and clinical data protected during generation?
  • What security and compliance documentation can be provided during evaluation?